Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Charlotte N Frederiks"'
Publikováno v:
Annals of Surgical Oncology.
Autor:
Charlotte N. Frederiks, B.E. Schenk, A. Alkhalaf, Roos E. Pouw, Arjun D. Koch, Auke Bogte, Bas L.A.M. Weusten, Frans Peters, Pieter J F de Jonge, M. H. M. G. Houben, Thjon J. Tang, Jessie Westerhof, Sanne N. van Munster, Wouter B. Nagengast, Erik J. Schoon, Lorenza Alvarez Herrero, Wouter L. Curvers, Jacques J. Bergman, Steffi E. M. van de Ven, Esther Nieuwenhuis
Publikováno v:
Van Munster, S N, Frederiks, C N, Nieuwenhuis, E A, Alvarez Herrero, L, Bogte, A, Alkhalaf, A, Schenk, B E, Schoon, E J, Curvers, W L, Koch, A D, Van De Ven, S E M, De Jonge, P J F, Tang, T J, Nagengast, W B, Peters, F T M, Westerhof, J, Houben, M H M G, Bergman, J J G H M, Pouw, R E & Weusten, B L A M 2022, ' Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia ', Endoscopy, vol. 54, no. 3, pp. 229-240 . https://doi.org/10.1055/a-1521-6318
Endoscopy, 54(3), 229-240. GEORG THIEME VERLAG KG
Endoscopy, 54(3), 229-240. Georg Thieme Verlag
Endoscopy, 54(3), 229-240. GEORG THIEME VERLAG KG
Endoscopy, 54(3), 229-240. Georg Thieme Verlag
Background Endoscopic eradication therapy with radiofrequency ablation (RFA) is effective in most patients with Barrett’s esophagus (BE). However, some patients experience poor healing and/or poor squamous regeneration. We evaluated incidence and t
Autor:
Charlotte N. Frederiks, Sanne N. van Munster, Esther A. Nieuwenhuis, Lorenza Alvarez Herrero, Alaa Alkhalaf, Boudewijn E. Schenk, Erik J. Schoon, Wouter L. Curvers, Arjun D. Koch, Pieter-Jan F. de Jonge, Thjon Tang, Wouter B. Nagengast, Jessie Westerhof, Martin H.M.G. Houben, Jacques J.G.H.M. Bergman, Roos E. Pouw, Bas L.A.M. Weusten
Publikováno v:
Clinical Gastroenterology and Hepatology. W.B. Saunders Ltd
Dutch Barrett Expert Centers 2023, ' Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low ', Clinical Gastroenterology and Hepatology, vol. 21, no. 9, pp. 2260-2269.e9 . https://doi.org/10.1016/j.cgh.2022.11.012, https://doi.org/10.1016/j.cgh.2022.11.012
Clinical gastroenterology and hepatology. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology. W.B. Saunders
Dutch Barrett Expert Centers 2023, ' Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett's Esophagus is Low ', Clinical Gastroenterology and Hepatology, vol. 21, no. 9, pp. 2260-2269.e9 . https://doi.org/10.1016/j.cgh.2022.11.012, https://doi.org/10.1016/j.cgh.2022.11.012
Clinical gastroenterology and hepatology. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology. W.B. Saunders
Background & Aims: Although random histological sampling from the esophagogastric junction (EGJ) after complete eradication of Barrett's esophagus (BE) is recommended, its clinical relevance is questionable. This study aimed to assess the incidence a
Autor:
Charlotte N. Frederiks, Anouk Overwater, Lorenza Alvarez Herrero, Alaa Alkhalaf, Ed Schenk, Alessandro Repici, Jacques J.G. H.M. Bergman, Roos E. Pouw, Raf Bisschops, Rehan J. Haidry, Torsten Beyna, Horst Neuhaus, Bas L.A. M. Weusten
Publikováno v:
Gastrointestinal Endoscopy, 96(5), 743-751.e4. Mosby Inc.
Gastrointestinal endoscopy, 96(5), 743-751.e4. Mosby Inc.
Frederiks, C N, Overwater, A, Alvarez Herrero, L, Alkhalaf, A, Schenk, E, Repici, A, Bergman, J J G H M, Pouw, R E, Bisschops, R, Haidry, R J, Beyna, T, Neuhaus, H & Weusten, B L A M 2022, ' Comparison of focal cryoballoon ablation with 10-and 8-second doses for treatment of Barrett's esophagus–related neoplasia : results from a prospective European multicenter study (with video) ', Gastrointestinal Endoscopy, vol. 96, no. 5, pp. 743-751.e4 . https://doi.org/10.1016/j.gie.2022.06.017
Gastrointestinal endoscopy, 96(5), 743-751.e4. Mosby Inc.
Frederiks, C N, Overwater, A, Alvarez Herrero, L, Alkhalaf, A, Schenk, E, Repici, A, Bergman, J J G H M, Pouw, R E, Bisschops, R, Haidry, R J, Beyna, T, Neuhaus, H & Weusten, B L A M 2022, ' Comparison of focal cryoballoon ablation with 10-and 8-second doses for treatment of Barrett's esophagus–related neoplasia : results from a prospective European multicenter study (with video) ', Gastrointestinal Endoscopy, vol. 96, no. 5, pp. 743-751.e4 . https://doi.org/10.1016/j.gie.2022.06.017
BACKGROUND AND AIMS: Focal cryoballoon ablation (FCBA) is currently being investigated for the treatment of Barrett's esophagus (BE)-related neoplasia in a European multicenter study (Euro-Coldplay study). After inclusion of 28 of 107 patients, the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbdf8b1dc41e2fcd10bb33256293042
https://research.vumc.nl/en/publications/a1749fd9-f2e6-4370-a738-789838c8104a
https://research.vumc.nl/en/publications/a1749fd9-f2e6-4370-a738-789838c8104a
Publikováno v:
European journal of gastroenterology & hepatology, 34(3), 354-357. Lippincott Williams and Wilkins
Although esophagectomy with or without (neo)adjuvant chemoradiation therapy is the current standard of care for patients with early esophageal adenocarcinoma with high-risk features or after nonradical endoscopic resection of an early esophageal aden
Autor:
Roos E. Pouw, FP Peters, A. Alkhalaf, Arjun D. Koch, Auke Bogte, L. Alvarez Herrero, WL Curvers, B.E. Schenk, Wouter B. Nagengast, Pjf de Jonge, B. L. A. M. Weusten, Sem van de Ven, Jessie Westerhof, SN van Munster, T Tang, Mhmg Houben, Jjghm Bergman, Erik J. Schoon, Charlotte N. Frederiks
Publikováno v:
ESGE Days 2021.
Publikováno v:
Gastrointestinal endoscopy clinics of North America. 31(1)
Cryotherapy is an ablation modality relying on freeze-thaw cycles to promote cell death through intracellular ice crystal formation, ischemia, and apoptosis. Currently, 2 different cryotherapy systems are available for esophageal use. The first is cr
Publikováno v:
Annals of Esophagus. 5:5-5
Barrett’s esophagus is a premalignant condition, and endoscopic eradication therapy is indicated upon development of early neoplasia. Therapy consists of endoscopic resection for visible lesions, if present, followed by endoscopic ablation for rema
Autor:
A. Alkhalaf, Jacques J. Bergman, Auke Bogte, Roos E. Pouw, Martin H. Houben, Arjun D. Koch, Frans Peters, Steffi E. M. van de Ven, Bas L. Weusten, B.E. Schenk, Jessie Westerhof, Sanne N. van Munster, Erik J. Schoon, Wouter B. Nagengast, Thjon J. Tang, Charlotte N. Frederiks, L. Alvarez Herrero, P.J.F. de Jonge, Wouter L. Curvers
Publikováno v:
Gastrointestinal Endoscopy. 93:AB283-AB284
Autor:
Jetske M. Meerum Terwogt, Henk-Jan Guchelaar, Judith R. Kroep, Agnes Jager, Jojanneke Ea Portielje, Joep Douma, Johan Berends, Ankie M.T. van der Velden, Steffen M de Groot, Maartje Los, Joan van den Bosch, Frank J.F. Jeurissen, Carolien H. Smorenburg, Aafke H. Honkoop, Hans J Braun, Bea Tanis, Charlotte N Frederiks, Tahar van der Straaten, Sabine C. Linn, Marien O den Boer, Siu W. Lam, Johanna Mgh van Riel, Epie Boven, Monique M.E.M. Bos
Publikováno v:
Cancer Research. 75:P6-08
Background Newly identified SNPs in genes encoding metabolizing enzymes (CYP2C8, CYP3A4) and drug target (TUBB2A) of paclitaxel have been associated with PNP1-3. A recent GWAS has found novel SNPs in EPHA5 and FGD4 possibly predictive for PNP4. Likew